(PEN)-UROTENSIN II (4-11)
|
urotensin-II 受體激動劑多肽4-11
|
473902-31-7
|
MARKSubstrate
|
MARK底物多肽
|
847991-34-8
|
IKKγ NBD Inhibitory Peptide
|
結合域多肽IKKγ NBD Inhibitory Peptide
|
372146-18-4
|
RR
|
二聚精氨酸
|
15483-27-9
|
Leu-Enkephalin, amide
|
受體激動劑多肽Leu-Enkephalin, amide
|
60117-24-0
|
FA-FGG
|
N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸
|
64967-39-1
|
GMAP (1-41), amide
|
甘丙肽信息相關肽 (GMAP)
|
132699-74-2
|
Lys3]–Bombesin
|
Lys3]-蛙皮素
|
66839-66-5
|
Xenopsin
|
爪蟾肽
|
51827-01-1
|
Tyr0]-Atriopeptin II (rat)
|
Tyr0]-心房肽II
|
117856-13-0
|
Galanin (1-13)-Spantide I
|
甘丙肽受體拮抗劑Galanin (1-13)-Spantide I
|
143868-20-6
|
NeuropeptideS(human)
|
內源性神經肽S受體激動劑,人源
|
412938-67-1
|
RRRRRR
|
五聚精氨酸
|
96337-25-6
|
TAK-448
|
KISS1R激動劑
|
740873-06-7
|
Obestatin,rat,mouse
|
Obestatin,rat,mouse/組合肽
|
869705-22-6
|
Trp3,Arg5]-Ghrelin (1-5)
|
Trp3,Arg5]-內源性激動劑肽1-5
|
848442-59-1
|
GLP-1(28-36)amide
|
GLP-1片段多肽GLP-1(28-36)amide
|
1225021-13-5
|
GLP-1(32-36)amide
|
GLP-1片段多肽GLP-1(32-36)amide
|
1417302-71-6
|
Neuropeptide Y(porcine)
|
神經肽Y(豬)
|
83589-17-7
|
[Lys5,MeLeu9,Nle10]neurokinin A(4-10)
|
neurokinin A改造片段多肽;[Lys5,MeLeu9,Nle10]neurokinin A(4-10)
|
137565-28-7
|
N-(p-Tosyl)-GPR-pNA
|
N-對甲苯磺?;?甘氨酰-脯氨酰-精氨酰對硝基苯胺
|
86890-95-1
|
BVD 10
|
NPY Y1 受體拮抗劑多肽
|
262418-00-8
|
Jingzhaotoxin III
|
NaV1.5通道阻斷劑多肽
|
925463-91-8
|
MM 419447
|
利那洛肽代謝物
|
1092457-78-7
|
Angstrom6/A6 Peptide
|
單鏈尿激酶纖溶酶原激活劑八肽
|
220334-14-5
|
Leucokinin I
|
白細胞激肽I
|
104600-89-7
|
M871
|
拮抗劑多肽M871
|
908844-75-7
|
PBP 10
|
甲酰肽受體 2 (FPR2) 拮抗劑多肽
|
794466-43-6
|
Fosgonimeton
|
肝細胞生長因子受體激動劑多肽
|
2093305-05-4
|
STh
|
熱穩(wěn)定毒素多肽
|
118447-40-8
|
c(RGDfK)
|
整合素抑制劑多肽cyclo (Arg-Gly-Asp-d-Phe-Lys)
|
500577-51-5
|
N-Acetyl lysyltyrosylcysteine amide
|
三肽抑制劑
|
1287585-40-3
|
c(RGDyV)
|
RGD環(huán)肽
|
1331910-33-8
|
P8RI
|
模擬肽P8RI
|
2147724-76-1
|
Acetyl-Hirudin (54-65) (sulfated)
|
乙酰水蛭素 (54-65)(硫酸化)
|
125441-00-1
|
Ras Inhibitory Peptide
|
Ras抑制肽
|
159088-48-9
|
N-Acetyl-Ala-Ala-Ala
|
N-乙?;?L-丙氨酰-L-丙氨酰-L-丙氨酸
|
19245-85-3
|
Enhanced Green Fluorescent Protein (EGFP) (200-208)
|
標記基因產物多肽
|
323198-39-6
|
Osteogenic Growth Peptide (10-14)
|
OGP(10-14)
|
105250-85-9
|
Gersizangitide
|
血管生成抑制劑
|
2417491-82-6
|
Tau Peptide (275-305)(Repeat 2 domain)
|
Tau蛋白R2片段多肽
|
330456-25-2
|
BAD (103-127),human
|
BH3結構域多肽
|
331762-68-6
|
Tat-beclin 1
|
自噬蛋白區(qū)域衍生肽
|
1423821-88-8
|
Cathepsin D and E FRET Substrate
|
熒光底物多肽
|
839730-93-7
|
β-Amyloid (1-38), mouse, rat
|
鼠源β淀粉樣蛋白1-38
|
186359-66-0
|
TfR-T12
|
轉鐵蛋白受體結合肽
|
344618-30-0
|
TIPP
|
阿片受體拮抗劑多肽
|
146369-65-5
|
pep2m
|
抑制劑多肽pep2m
|
243843-42-7
|
Fmoc-Ala-Glu-Asn-Lys-NH2
|
AEP抑制肽
|
220701-06-4
|
Kaliotoxin
|
強效阻斷劑Kaliotoxin
|
145199-73-1
|
Acetyl Pentapeptide-1
|
乙?;咫?1
|
97530-32-0
|
Caerulein
|
雨蛙素
|
17650-98-5
|
glutathione monoisopropyl ester
|
谷胱甘肽一異丙酯(還原)
|
97451-46-2
|
FTase Inhibitor II
|
FTase 抑制劑 II
|
156707-43-6
|
insulin-likegrowthfactorI(57-70)
|
噬菌體 M2終點蛋白質
|
123618-03-1
|
α-Synuclein (61-75)
|
α-突刺蛋白61-75
|
440645-08-9
|
Dentonin (AC-100)
|
促進成骨肽
|
400090-20-2
|
L 659877
|
NK-2受體拮抗劑多肽L 659877
|
125989-12-0
|
β-Defensin 2 (human)
|
β-防御素2
|
372146-20-8
|
LCKLSL
|
AnxA2抑制劑多肽
|
533902-29-3
|
TNF-α Antagonist
|
TNF-α拮抗劑
|
199999-60-5
|
TRV055
|
GVYIHPF配體多肽
|
25849-90-5
|
TRV120056
|
激動劑多肽TRV120056
|
40678-47-5
|
LyP-1
|
腫瘤歸巢肽LyP-1
|
454487-07-1
|
Pancreatic Polypeptide (bovine)
|
Pancreatic Polypeptide,bovine
|
179986-89-1
|
Flagelin 22
|
細菌鞭毛素片段肽
|
304642-91-9
|
HAE
|
HAE
|
64111-99-5
|
LKKTETQ
|
胸腺素調節(jié)蛋白多肽
|
476014-70-7
|
Huwentoxin IV
|
通道阻滯劑多肽Huwentoxin IV
|
526224-73-7
|
BeKm 1
|
通道阻滯劑多肽BeKm 1
|
524962-01-4
|
Dabcyl-YVADAPV-Edans
|
熒光底物肽
|
161877-70-9
|
COG1410
|
載脂蛋白E衍生肽
|
878009-24-6
|
Phrixotoxin 3
|
阻滯劑多肽Phrixotoxin 3
|
880886-00-0
|
GIP (1-39)
|
腸促胰島素激素多肽1-39
|
725474-97-5
|
RF9
|
神經肽FF受體拮抗劑RF9
|
876310-60-0
|
Locustachykinin I
|
昆蟲速激肽相關肽Locustachykinin I
|
126985-97-5
|
Corticotropin Releasing Factor,ovine
|
可的瑞林
|
79804-71-0
|
st-Ht31
|
st-Ht31
|
188425-80-1
|
[Ala92]-p16 (84-103)
|
[Ala92]-p16 (84-103)
|
189064-08-2
|
R 715
|
R 715
|
185052-09-9
|
N-p-Tosyl-Gly-Pro-Lys-pNA (acetate)
|
N-p-Tosyl-Gly-Pro-Lys-pNA (acetate)
|
88793-79-7
|
Histone H3 (116-136),C116-136
|
HISTONE H3 (116-136),C116-136
|
917103-17-4
|
HER2neu(654-662) GP2
|
HER2neu(654-662) GP2
|
160790-21-6
|
Phytochelatin 2
|
Phytochelatin 2重金屬結合肽
|
95014-75-8
|
HXR9
|
HXR9細胞滲透性多肽
|
917953-08-3
|
MMPs substrate Fluorogenic
|
MMPs substrate Fluorogenic熒光底物肽
|
720710-69-0
|
GPLGIAGQ
|
GPLGIAGQ
|
109053-09-0
|
Cenupatide
|
Ac-Arg-Aib-Arg-α(Me)Phe-NH2
|
1006388-38-0
|
Dusquetide
|
天然防御調節(jié)因子SGX942
|
931395-42-5
|
GLP-2(3-33)
|
GLP-2(3-33)
|
275801-62-2
|
Calmodulin Binding Peptide 1
|
鈣調蛋白結合肽1
|
104041-80-7
|
Phospho-Glycogen Synthase Peptide-2(substrate)
|
磷酸糖原合酶肽2(底物)
|
851366-97-7
|
H-Glu(Ala-OH)-OH
|
L-γ-谷氨酰-L-丙氨酸
|
5875-41-2
|
H-Ile-Ile-Ile-OH
|
三聚異亮氨酸
|
114148-95-7
|
T7 Tag Peptide
|
T7標簽肽
|
245445-88-9
|
Heterophyllin B
|
太子參環(huán)肽b
|
145459-19-4
|
SNX 482
|
R型CaV2.3鈣通道阻滯劑
|
203460-30-4
|
DX600 TFA
|
ACE2特異性抑制劑多肽
|
478188-26-0
|
DOTATATE
|
DOTA-(Tyr3)-OCTREOTATE
|
177943-89-4
|
LCMV gp33-41
|
KAVYNFATM
|
151705-84-9
|